Cargando…
Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation
Although glucocorticoid (GC) is widely used for treating hematopoietic malignancies including adult T-cell leukemia (ATL), the mechanism by which leukemic cells become resistant to GC in the clinical course remains unclear. Using a series of T-cell lines infected with human T lymphotropic virus type...
Autores principales: | Chen, Z, Lopez-Ramos, D A, Yoshihara, E, Maeda, Y, Masutani, H, Sugie, K, Maeda, M, Yodoi, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072512/ https://www.ncbi.nlm.nih.gov/pubmed/21151022 http://dx.doi.org/10.1038/leu.2010.286 |
Ejemplares similares
-
Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus
por: Masutani, Hiroshi, et al.
Publicado: (2012) -
Deficiency of Thioredoxin Binding Protein-2 (TBP-2) Enhances TGF-β Signaling and Promotes Epithelial to Mesenchymal Transition
por: Masaki, So, et al.
Publicado: (2012) -
TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis
por: Yoshihara, Eiji
Publicado: (2020) -
Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity
por: Yoshihara, Eiji, et al.
Publicado: (2010) -
Thioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases
por: Yoshihara, Eiji, et al.
Publicado: (2014)